POU2F2 (POU class 2 homeobox 2) is a sequence-specific DNA-binding transcription factor that regulates gene expression through RNA polymerase II-mediated transcription. The protein functions as a transcriptional activator, notably activating the U2 small nuclear RNA promoter and positively regulating interleukin-6 production [UniProt]. POU2F2 operates through specific DNA-binding mechanisms, forming protein complexes with other transcriptional regulators to control target gene expression 1. In immune contexts, POU2F2 plays crucial roles in T cell and NK cell function, where it contributes to a core stemness program in exhausted CD8+ T cells and enhances interferon-gamma transcription in NK cells through OCT2-dependent mechanisms 23. The transcription factor demonstrates significant clinical relevance across multiple diseases. In cancer, POU2F2 is implicated in drug resistance mechanisms in multiple myeloma, where it forms complexes with RUNX proteins to activate oncogenes including IRF4, JUNB, and BCL2 1. It also contributes to tumor-associated macrophage activation in colorectal cancer through the MIF/CD44/POU2F2/BCL9L signaling axis 4. Additionally, POU2F2 is involved in cardiovascular pathology, cooperating with CEBPB to enhance endothelin-1 expression in vascular smooth muscle cells associated with hypertension 5. These diverse roles position POU2F2 as a potential therapeutic target across oncological and cardiovascular contexts.